NPI: 1518903350 · MIRAMAR, FL 33025 · Clinical Medical Laboratory · NPI assigned 06/21/2006
Authorized official TIMMERMAN, LEAH controls 20+ related entities in our dataset. Read more
| Authorized Official | TIMMERMAN, LEAH (VICE PRESIDENT) |
| Parent Organization | QUEST DIAGNOSTICS INCORPORATED |
| NPI Enumeration Date | 06/21/2006 |
Other providers sharing the same authorized official: TIMMERMAN, LEAH
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 623,973 | $1.96M |
| 2019 | 3,283,267 | $22.38M |
| 2020 | 2,655,076 | $21.39M |
| 2021 | 3,442,049 | $30.37M |
| 2022 | 4,992,070 | $46.42M |
| 2023 | 5,376,237 | $41.63M |
| 2024 | 3,969,250 | $33.43M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 677,725 | 636,603 | $11.49M |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 135,259 | 123,806 | $10.93M |
| 81420 | Fetal chromosomal aneuploidy genomic sequence analysis panel | 30,004 | 28,585 | $10.75M |
| 80061 | Lipid panel | 1,450,934 | 1,341,355 | $9.41M |
| 81220 | CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants | 27,025 | 25,687 | $7.09M |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 670,545 | 629,729 | $7.05M |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 507,400 | 462,225 | $6.60M |
| 84443 | Thyroid stimulating hormone (TSH) | 1,060,799 | 970,676 | $6.12M |
| 80053 | Comprehensive metabolic panel | 1,683,206 | 1,510,480 | $5.58M |
| 83036 | Hemoglobin; glycosylated (A1C) | 972,518 | 893,728 | $5.07M |
| 86003 | 97,808 | 85,307 | $4.48M | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1,634,249 | 1,476,626 | $4.27M |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 473,857 | 452,767 | $4.15M |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | 200,015 | 193,825 | $3.47M |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 115,856 | 107,854 | $3.43M |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | 167,841 | 161,509 | $3.04M |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | 71,221 | 66,467 | $2.83M |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | 150,302 | 140,212 | $2.69M |
| 87086 | Culture, bacterial; quantitative colony count, urine | 577,249 | 522,669 | $2.61M |
| 87088 | 352,948 | 319,767 | $2.51M | |
| 80050 | General health panel | 215,670 | 210,095 | $2.49M |
| 84439 | 490,215 | 457,224 | $2.45M | |
| 82728 | 246,859 | 226,283 | $2.22M | |
| 81229 | 6,222 | 5,890 | $2.16M | |
| 80074 | 67,125 | 62,835 | $1.80M | |
| 86803 | 266,376 | 252,379 | $1.80M | |
| 82746 | 236,206 | 212,956 | $1.80M | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 31,335 | 26,710 | $1.75M |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 18,600 | 17,487 | $1.71M |
| 80055 | 64,962 | 61,789 | $1.63M | |
| 81513 | 31,859 | 29,268 | $1.60M | |
| 86480 | 53,615 | 49,474 | $1.51M | |
| 82607 | 318,173 | 286,893 | $1.45M | |
| 87340 | 196,629 | 186,676 | $1.42M | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 50,210 | 46,826 | $1.15M |
| 87536 | 52,864 | 44,772 | $1.09M | |
| 83655 | 141,884 | 137,103 | $1.00M | |
| 82785 | 93,267 | 87,346 | $958K | |
| 84403 | 91,457 | 84,598 | $947K | |
| 81001 | 790,310 | 715,061 | $859K | |
| 86235 | 47,240 | 24,960 | $821K | |
| 82105 | 73,330 | 69,663 | $816K | |
| 88142 | 57,079 | 55,112 | $800K | |
| 81511 | 12,415 | 11,974 | $800K | |
| 87070 | 194,412 | 182,917 | $796K | |
| 87081 | 158,204 | 152,389 | $795K | |
| 86038 | 92,645 | 81,972 | $789K | |
| 84153 | 121,801 | 108,995 | $783K | |
| 81443 | 1,697 | 1,579 | $764K | |
| 87522 | Neg quan hep c or qual rna | 34,327 | 30,922 | $764K |
| 36415 | Collection of venous blood by venipuncture | 608,150 | 507,896 | $702K |
| 82670 | 48,545 | 45,534 | $681K | |
| 80081 | 28,883 | 28,120 | $680K | |
| 87209 | 52,699 | 46,429 | $648K | |
| 86592 | 338,622 | 321,681 | $644K | |
| 87799 | 62,513 | 30,215 | $636K | |
| 85027 | 267,694 | 246,491 | $595K | |
| 87186 | 158,304 | 141,908 | $591K | |
| 84146 | 59,712 | 56,543 | $591K | |
| 84702 | 95,644 | 83,422 | $581K | |
| 87902 | 5,468 | 5,032 | $581K | |
| 83001 | 72,011 | 68,224 | $579K | |
| 82784 | 69,902 | 64,041 | $561K | |
| 83970 | 46,462 | 40,615 | $548K | |
| 86696 | 60,338 | 57,120 | $538K | |
| 83550 | 214,116 | 195,602 | $525K | |
| 82627 | 31,527 | 29,852 | $523K | |
| 84481 | 67,257 | 61,201 | $494K | |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 2,774 | 2,695 | $483K |
| 81329 | 14,183 | 13,330 | $477K | |
| 83540 | 241,266 | 220,429 | $466K | |
| 84402 | 45,476 | 42,639 | $457K | |
| 86787 | 46,859 | 44,545 | $451K | |
| 82570 | 291,868 | 260,199 | $449K | |
| 86800 | 43,397 | 39,920 | $426K | |
| 83002 | 65,544 | 62,137 | $394K | |
| 83525 | 75,966 | 72,675 | $379K | |
| 86364 | 28,445 | 26,737 | $368K | |
| 87512 | 29,230 | 26,391 | $355K | |
| 86360 | 36,645 | 31,006 | $353K | |
| 85652 | 166,522 | 147,125 | $350K | |
| 82652 | 27,418 | 24,574 | $348K | |
| 86008 | 18,079 | 15,541 | $342K | |
| 84480 | 65,966 | 60,004 | $341K | |
| 87077 | 152,134 | 137,108 | $326K | |
| 88141 | 31,470 | 30,428 | $315K | |
| 82274 | 52,041 | 48,997 | $313K | |
| 86695 | 56,200 | 53,279 | $312K | |
| 86769 | 19,401 | 16,692 | $311K | |
| 84436 | 151,842 | 138,180 | $309K | |
| 82043 | 238,742 | 214,742 | $300K | |
| 83020 | 51,827 | 49,462 | $291K | |
| 80048 | Basic metabolic panel (calcium, ionized) | 110,949 | 96,745 | $289K |
| 83735 | 81,347 | 64,462 | $284K | |
| 84479 | 97,268 | 89,019 | $280K | |
| 83013 | 19,791 | 18,043 | $271K | |
| 80349 | 20,193 | 18,908 | $269K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 6,899 | 6,587 | $267K |
| 88185 | 1,383 | 1,272 | $264K | |
| 86140 | 150,997 | 131,859 | $264K | |
| 83520 | 47,593 | 31,120 | $261K | |
| 86376 | 62,245 | 56,609 | $260K | |
| 88342 | 4,472 | 4,035 | $251K | |
| 82465 | 69,663 | 68,097 | $248K | |
| 86160 | 26,499 | 19,862 | $247K | |
| 86147 | 16,297 | 9,367 | $243K | |
| 86665 | 14,697 | 13,739 | $241K | |
| 84144 | 28,707 | 26,363 | $238K | |
| 87563 | 16,919 | 16,097 | $236K | |
| 85660 | 44,289 | 42,539 | $234K | |
| 86146 | 13,754 | 8,191 | $230K | |
| 85730 | 87,334 | 77,234 | $229K | |
| 82950 | 118,016 | 113,801 | $226K | |
| 87901 | 3,161 | 2,743 | $226K | |
| 86704 | 60,679 | 56,378 | $218K | |
| 86706 | 58,057 | 54,525 | $217K | |
| 82150 | 28,635 | 26,000 | $209K | |
| 84681 | 17,934 | 16,574 | $206K | |
| 80361 | 20,344 | 19,149 | $205K | |
| 86762 | 34,658 | 32,718 | $202K | |
| 82550 | 42,066 | 35,568 | $201K | |
| 81243 | 14,411 | 13,537 | $199K | |
| 86225 | 27,296 | 22,892 | $196K | |
| 86780 | 33,768 | 31,397 | $195K | |
| 82378 | 25,708 | 22,132 | $191K | |
| 87631 | 4,807 | 4,569 | $183K | |
| 86317 | 33,547 | 30,422 | $182K | |
| 82951 | 28,516 | 27,605 | $182K | |
| 87449 | 25,905 | 23,197 | $177K | |
| 86850 | 36,947 | 35,425 | $177K | |
| 86708 | 50,392 | 46,937 | $170K | |
| 81596 | 5,521 | 5,037 | $170K | |
| 84445 | 7,936 | 7,431 | $165K | |
| 80348 | 11,150 | 10,340 | $164K | |
| 88230 | 3,195 | 3,040 | $162K | |
| 82533 | 18,003 | 16,161 | $161K | |
| 83718 | 56,786 | 55,862 | $159K | |
| 83615 | 39,332 | 34,886 | $158K | |
| 80076 | 60,259 | 56,683 | $158K | |
| 84305 | 15,183 | 14,422 | $156K | |
| 83880 | 13,433 | 11,536 | $156K | |
| 87506 | 1,965 | 1,873 | $154K | |
| 87480 | 11,895 | 11,175 | $148K | |
| 83516 | 37,692 | 25,645 | $147K | |
| 86481 | 2,815 | 2,688 | $143K | |
| 80365 | 20,020 | 18,897 | $142K | |
| 83021 | 25,559 | 24,377 | $140K | |
| 84550 | 108,979 | 95,160 | $138K | |
| 83498 | 12,717 | 12,256 | $134K | |
| 87177 | 52,577 | 46,290 | $133K | |
| 82024 | 5,967 | 5,448 | $131K | |
| 82947 | 46,314 | 44,105 | $131K | |
| 83993 | 15,117 | 14,192 | $130K | |
| 82672 | 11,496 | 10,661 | $129K | |
| 80373 | 10,377 | 9,720 | $129K | |
| 80346 | 11,723 | 10,973 | $126K | |
| 86334 | 14,860 | 12,600 | $123K | |
| 88262 | 3,161 | 3,003 | $123K | |
| 87900 | 3,154 | 2,737 | $120K | |
| 86200 | 28,650 | 24,475 | $119K | |
| 84270 | 17,856 | 16,755 | $119K | |
| 87660 | 13,213 | 12,267 | $118K | |
| 85610 | 115,256 | 98,455 | $114K | |
| 80354 | 10,458 | 9,797 | $114K | |
| 82977 | 27,783 | 24,305 | $112K | |
| 87529 | 4,695 | 2,973 | $106K | |
| 80197 | 16,119 | 11,614 | $106K | |
| 82677 | 9,757 | 9,324 | $104K | |
| 86300 | 13,118 | 10,138 | $103K | |
| 87147 | 58,698 | 55,698 | $100K | |
| 87906 | 1,512 | 1,281 | $100K | |
| 87427 | 32,750 | 30,876 | $100K | |
| 86431 | 56,764 | 50,506 | $98K | |
| 87338 | 22,442 | 20,965 | $97K | |
| 85240 | 8,242 | 7,907 | $96K | |
| 82248 | 75,099 | 65,144 | $96K | |
| 87075 | 18,608 | 17,095 | $93K | |
| 87205 | 26,480 | 24,125 | $92K | |
| 84154 | 17,141 | 15,430 | $92K | |
| 88341 | 1,719 | 1,661 | $91K | |
| 86359 | 19,537 | 16,213 | $91K | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 14,894 | 12,875 | $90K |
| 80323 | 7,913 | 7,404 | $90K | |
| 82085 | 5,991 | 5,077 | $90K | |
| 87497 | 5,056 | 3,543 | $89K | |
| 80358 | 10,701 | 10,014 | $89K | |
| 84207 | 5,890 | 5,324 | $87K | |
| 83690 | 36,455 | 33,088 | $86K | |
| 87517 | 4,796 | 4,353 | $86K | |
| 88312 | 1,554 | 1,518 | $85K | |
| 80164 | 14,977 | 13,774 | $85K | |
| 87045 | 34,871 | 32,839 | $84K | |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 1,674 | 1,589 | $83K |
| 86255 | 19,680 | 13,093 | $83K | |
| 86304 | 9,817 | 8,630 | $82K | |
| 83521 | 5,086 | 3,460 | $81K | |
| 82157 | 6,266 | 6,023 | $81K | |
| 86644 | 5,780 | 5,378 | $80K | |
| 86021 | 9,027 | 7,672 | $80K | |
| 87329 | 22,508 | 21,227 | $79K | |
| 84182 | 1,571 | 1,112 | $78K | |
| 86039 | 26,393 | 22,784 | $78K | |
| 84156 | 76,231 | 66,687 | $76K | |
| 87046 | 16,386 | 15,174 | $74K | |
| 81003 | 108,715 | 99,669 | $74K | |
| 82103 | 4,697 | 4,313 | $73K | |
| 81257 | 2,347 | 2,151 | $71K | |
| 80324 | 6,812 | 6,362 | $70K | |
| 80321 | 7,330 | 6,716 | $69K | |
| 80069 | 25,868 | 22,709 | $69K | |
| 87150 | 4,632 | 4,384 | $68K | |
| 85246 | 8,006 | 7,741 | $67K | |
| 84466 | 10,283 | 9,564 | $65K | |
| 84425 | 8,900 | 8,101 | $63K | |
| 86664 | 12,902 | 12,310 | $62K | |
| 86336 | 9,875 | 9,441 | $61K | |
| 86361 | 12,854 | 10,656 | $60K | |
| 81512 | 2,182 | 2,114 | $60K | |
| 86341 | 4,697 | 3,312 | $60K | |
| 84703 | 22,871 | 21,672 | $60K | |
| 80320 | 6,798 | 6,404 | $60K | |
| 83921 | 7,921 | 6,919 | $59K | |
| 81241 | 2,374 | 2,173 | $59K | |
| 80356 | 6,134 | 5,662 | $59K | |
| 86765 | 12,309 | 11,371 | $58K | |
| 87510 | 11,875 | 11,157 | $58K | |
| 80353 | 7,072 | 6,514 | $58K | |
| 87481 | 10,271 | 7,816 | $58K | |
| 88304 | 2,528 | 2,429 | $57K | |
| 82330 | 7,566 | 6,758 | $57K | |
| 86357 | 5,500 | 4,906 | $56K | |
| 84100 | 46,909 | 37,180 | $56K | |
| 82542 | 6,875 | 6,041 | $56K | |
| 86355 | 6,228 | 5,590 | $56K | |
| 86258 | 4,926 | 4,586 | $55K | |
| 88112 | 2,263 | 1,943 | $55K | |
| 85018 | 46,046 | 44,175 | $54K | |
| 80362 | 6,465 | 6,041 | $54K | |
| 85045 | 35,307 | 31,814 | $54K | |
| 81401 | 592 | 539 | $54K | |
| 80368 | 6,539 | 6,127 | $53K | |
| 80337 | 6,222 | 5,870 | $53K | |
| 85245 | 7,302 | 7,069 | $52K | |
| 84165 | 20,666 | 17,755 | $52K | |
| 85014 | 38,266 | 36,794 | $52K | |
| 83992 | 7,185 | 6,683 | $51K | |
| 85247 | 4,871 | 4,715 | $49K | |
| 83090 | 15,042 | 12,788 | $49K | |
| 86141 | 13,776 | 12,020 | $49K | |
| 82653 | 2,953 | 2,751 | $48K | |
| 86812 | 4,860 | 4,284 | $48K | |
| 82626 | 2,997 | 2,822 | $48K | |
| 82787 | 3,646 | 3,159 | $48K | |
| 82140 | 7,883 | 7,144 | $48K | |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | 1,273 | 1,206 | $48K |
| 81025 | 6,836 | 6,448 | $47K | |
| 80370 | 6,145 | 5,801 | $47K | |
| 80377 | 5,685 | 5,342 | $46K | |
| 80338 | 6,220 | 5,878 | $45K | |
| 82088 | 3,074 | 2,752 | $45K | |
| 86777 | 6,213 | 5,873 | $45K | |
| 82139 | 3,119 | 2,895 | $45K | |
| 84460 | 30,674 | 27,977 | $45K | |
| 82668 | 4,243 | 3,789 | $45K | |
| 86735 | 11,896 | 11,006 | $45K | |
| 80345 | 8,272 | 7,712 | $45K | |
| 88184 | 1,358 | 1,282 | $44K | |
| G0483 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed | 537 | 500 | $44K |
| 88313 | 271 | 260 | $44K | |
| 86335 | 2,685 | 2,267 | $44K | |
| 87625 | 4,472 | 4,214 | $44K | |
| 82247 | 22,371 | 19,076 | $43K | |
| 86709 | 7,362 | 6,977 | $43K | |
| 86900 | 32,578 | 31,107 | $43K | |
| 86774 | 7,743 | 7,264 | $43K | |
| 82565 | 27,807 | 24,411 | $43K | |
| 80326 | 6,185 | 5,836 | $42K | |
| 82040 | 15,988 | 14,792 | $41K | |
| 85300 | 2,249 | 2,066 | $40K | |
| 80359 | 3,529 | 3,120 | $40K | |
| 80369 | 5,552 | 5,334 | $40K | |
| 86301 | 6,459 | 5,485 | $39K | |
| 81382 | 597 | 534 | $39K | |
| 80363 | 4,577 | 4,384 | $39K | |
| 87255 | 1,989 | 1,905 | $39K | |
| 82310 | 19,632 | 17,952 | $39K | |
| 86648 | 7,209 | 6,778 | $38K | |
| 80177 | 7,036 | 6,456 | $37K | |
| 80372 | 5,173 | 4,752 | $37K | |
| 86870 | 6,257 | 5,843 | $35K | |
| 84630 | 7,631 | 6,974 | $35K | |
| 82525 | 4,578 | 4,115 | $35K | |
| 80202 | 4,194 | 1,821 | $35K | |
| 84450 | 26,327 | 24,084 | $34K | |
| 83519 | 4,918 | 3,215 | $34K | |
| 85060 | 4,217 | 4,019 | $34K | |
| 86645 | 5,244 | 4,925 | $34K | |
| 87535 | 2,155 | 1,973 | $34K | |
| 82390 | 5,587 | 5,199 | $34K | |
| 82657 | 2,663 | 1,734 | $33K | |
| 86705 | 8,978 | 8,469 | $32K | |
| 86381 | 3,888 | 3,395 | $32K | |
| 81270 | 671 | 604 | $32K | |
| 86162 | 5,744 | 5,187 | $31K | |
| 80360 | 3,500 | 3,144 | $30K | |
| 82731 | 1,354 | 1,025 | $30K | |
| 80332 | 3,641 | 3,520 | $29K | |
| 84134 | 4,866 | 4,178 | $29K | |
| 81400 | 843 | 442 | $29K | |
| 85613 | 8,003 | 7,095 | $28K | |
| 80366 | 3,815 | 3,483 | $28K | |
| 86060 | 4,646 | 4,355 | $28K | |
| 88189 | 1,216 | 1,148 | $28K | |
| 86747 | 1,956 | 1,820 | $28K | |
| 82952 | 22,950 | 22,191 | $27K | |
| 87324 | 9,593 | 8,715 | $27K | |
| 83010 | 5,862 | 5,179 | $27K | |
| 82610 | 4,169 | 3,921 | $27K | |
| 86778 | 4,842 | 4,606 | $27K | |
| 80339 | 4,177 | 4,051 | $27K | |
| 86901 | 32,521 | 31,055 | $26K | |
| 80374 | 2,874 | 2,758 | $26K | |
| 84244 | 3,152 | 2,884 | $26K | |
| 85306 | 2,745 | 2,497 | $26K | |
| 84520 | 18,640 | 16,742 | $25K | |
| 80178 | 5,988 | 5,453 | $25K | |
| 80342 | 3,637 | 3,517 | $24K | |
| 85379 | 4,650 | 4,166 | $24K | |
| 81206 | 438 | 387 | $24K | |
| 83003 | 2,110 | 1,752 | $24K | |
| 84432 | 5,663 | 5,178 | $24K | |
| 84482 | 1,903 | 1,736 | $24K | |
| 84590 | 4,075 | 3,806 | $23K | |
| 80329 | 4,287 | 4,152 | $22K | |
| 86618 | 2,863 | 2,591 | $22K | |
| 87101 | 5,075 | 4,814 | $22K | |
| 82164 | 3,806 | 3,293 | $22K | |
| 81376 | 425 | 402 | $21K | |
| 81240 | 1,653 | 1,510 | $21K | |
| 80156 | 2,478 | 2,238 | $21K | |
| 84075 | 13,994 | 12,723 | $21K | |
| 82379 | 2,686 | 2,536 | $21K | |
| 84080 | 1,575 | 1,428 | $21K | |
| 85041 | 21,517 | 20,627 | $21K | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | 2,196 | 1,787 | $21K |
| 81291 | 712 | 647 | $21K | |
| 87662 | 1,086 | 1,010 | $21K | |
| 86337 | 2,133 | 2,026 | $20K | |
| 87350 | 2,841 | 2,694 | $20K | |
| 86617 | 1,804 | 1,496 | $20K | |
| 82107 | 948 | 868 | $19K | |
| 84155 | 17,540 | 15,615 | $19K | |
| 82172 | 4,150 | 3,511 | $19K | |
| 84478 | 8,616 | 6,724 | $19K | |
| 86015 | 4,481 | 3,842 | $19K | |
| 87040 | 3,138 | 2,665 | $19K | |
| 80175 | 3,436 | 3,225 | $18K | |
| 82104 | 2,085 | 1,957 | $18K | |
| 83835 | 2,059 | 1,801 | $18K | |
| 82530 | 2,253 | 1,921 | $18K | |
| 85303 | 2,613 | 2,416 | $18K | |
| 86231 | 2,318 | 2,168 | $17K | |
| 81361 | 629 | 436 | $17K | |
| 87493 | 1,686 | 1,510 | $17K | |
| 81205 | 400 | 355 | $17K | |
| 80357 | 2,453 | 2,213 | $17K | |
| 80367 | 1,874 | 1,663 | $17K | |
| 86611 | 2,283 | 1,543 | $16K | |
| 86593 | 14,811 | 13,401 | $16K | |
| 80364 | 1,871 | 1,657 | $16K | |
| 87102 | 3,962 | 3,644 | $16K | |
| 80299 | 1,957 | 1,757 | $16K | |
| 84166 | 3,615 | 3,121 | $16K | |
| 83918 | 1,726 | 1,644 | $16K | |
| 80333 | 1,862 | 1,653 | $15K | |
| 81364 | 123 | 113 | $15K | |
| 83014 | 8,509 | 7,751 | $15K | |
| 82679 | 1,382 | 1,278 | $15K | |
| 87425 | 2,029 | 1,934 | $15K | |
| 82747 | 1,624 | 1,484 | $15K | |
| 85384 | 2,397 | 2,220 | $15K | |
| 82175 | 1,474 | 1,322 | $15K | |
| 83883 | 5,583 | 2,563 | $14K | |
| 86738 | 1,767 | 1,655 | $14K | |
| 82232 | 3,126 | 2,678 | $14K | |
| 83605 | 2,059 | 1,937 | $14K | |
| 80340 | 1,857 | 1,649 | $14K | |
| 86880 | 2,547 | 2,329 | $14K | |
| 86682 | 1,846 | 1,658 | $14K | |
| 82955 | 2,274 | 2,035 | $14K | |
| 86308 | 2,913 | 2,763 | $14K | |
| 80183 | 2,399 | 2,242 | $14K | |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | 8,081 | 6,655 | $13K |
| 80344 | 1,874 | 1,661 | $13K | |
| 83695 | 4,586 | 3,882 | $13K | |
| 84446 | 2,639 | 2,421 | $13K | |
| 86001 | 2,794 | 2,621 | $13K | |
| 0346U | 412 | 338 | $12K | |
| 83631 | 1,483 | 1,411 | $12K | |
| 82397 | 3,032 | 2,799 | $12K | |
| 81479 | Unlisted molecular pathology procedure | 760 | 670 | $12K |
| 80051 | 6,380 | 5,853 | $12K | |
| 82985 | 4,803 | 4,061 | $12K | |
| 83721 | 8,395 | 7,315 | $11K | |
| 82340 | 2,711 | 2,440 | $11K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 1,744 | 1,685 | $11K |
| 86684 | 2,406 | 2,280 | $11K | |
| 85598 | 1,512 | 1,351 | $11K | |
| 82166 | 692 | 684 | $11K | |
| 86036 | 4,297 | 3,607 | $11K | |
| 86671 | 2,911 | 1,643 | $11K | |
| 81255 | 419 | 374 | $11K | |
| 80159 | 1,898 | 1,276 | $10K | |
| 80185 | 1,814 | 1,599 | $10K | |
| 80330 | 2,280 | 2,053 | $10K | |
| 87076 | 3,971 | 3,671 | $10K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 783 | 760 | $10K |
| 81250 | 533 | 419 | $10K | |
| 81279 | 218 | 177 | $10K | |
| 82384 | 827 | 740 | $10K | |
| 87206 | 4,702 | 4,057 | $10K | |
| 83704 | 1,582 | 1,328 | $10K | |
| 86161 | 1,496 | 1,378 | $10K | |
| 80235 | 808 | 755 | $9K | |
| 83698 | 1,350 | 1,062 | $9K | |
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed | 130 | 125 | $9K |
| 81381 | 325 | 274 | $9K | |
| 81015 | 8,914 | 8,219 | $9K | |
| 81251 | 419 | 367 | $9K | |
| 81200 | 498 | 417 | $9K | |
| 81330 | 417 | 369 | $8K | |
| G0145 | Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision | 4,839 | 3,947 | $8K |
| 89055 | 2,862 | 2,621 | $8K | |
| 83625 | 1,705 | 1,567 | $8K | |
| 84597 | 745 | 699 | $8K | |
| 83825 | 1,613 | 1,441 | $8K | |
| 84132 | 4,301 | 3,892 | $8K | |
| 85004 | 2,337 | 2,149 | $8K | |
| 82507 | 523 | 453 | $8K | |
| 80145 | 521 | 494 | $8K | |
| 82239 | 971 | 908 | $8K | |
| 80162 | 1,091 | 899 | $8K | |
| 87185 | 4,043 | 3,698 | $8K | |
| 84376 | 2,529 | 2,427 | $7K | |
| 80195 | 1,357 | 1,110 | $7K | |
| 87800 | 383 | 380 | $7K | |
| 86702 | 2,828 | 2,480 | $7K | |
| 81290 | 403 | 360 | $7K | |
| 84295 | 5,297 | 4,841 | $7K | |
| 84255 | 635 | 560 | $7K | |
| 84238 | 354 | 327 | $7K | |
| 81209 | 494 | 403 | $7K | |
| 85007 | 6,626 | 6,109 | $7K | |
| 87328 | 1,310 | 1,204 | $7K | |
| 81260 | 480 | 387 | $7K | |
| 87650 | 588 | 569 | $7K | |
| 81242 | 413 | 365 | $7K | |
| 86794 | 646 | 620 | $6K | |
| 84210 | 928 | 881 | $6K | |
| 82705 | 2,037 | 1,882 | $6K | |
| 86148 | 2,137 | 1,119 | $6K | |
| 80165 | 1,068 | 1,007 | $6K | |
| 82017 | 1,112 | 1,058 | $6K | |
| 87521 | Neg quan hep c or qual rna | 392 | 377 | $6K |
| 86343 | 907 | 813 | $6K | |
| 87107 | 1,619 | 1,525 | $6K | |
| 86707 | 1,642 | 1,523 | $6K | |
| 86340 | 843 | 757 | $6K | |
| 82374 | 4,409 | 4,054 | $6K | |
| 83630 | 665 | 622 | $6K | |
| 85049 | 3,991 | 3,558 | $6K | |
| 84484 | 1,345 | 1,155 | $6K | |
| 81256 | 190 | 178 | $6K | |
| 82435 | 4,570 | 4,213 | $6K | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 154 | 134 | $5K |
| 84143 | 629 | 596 | $5K | |
| 85302 | 702 | 658 | $5K | |
| 85048 | 4,575 | 4,227 | $5K | |
| 86886 | 2,984 | 2,779 | $5K | |
| 82575 | 1,377 | 1,298 | $5K | |
| 80355 | 1,763 | 1,679 | $5K | |
| 83935 | 1,605 | 1,423 | $5K | |
| 87467 | 458 | 425 | $5K | |
| 85250 | 674 | 641 | $5K | |
| 87106 | 1,543 | 1,454 | $5K | |
| 86631 | 680 | 644 | $5K | |
| 86256 | 1,286 | 1,100 | $4K | |
| 85597 | 800 | 699 | $4K | |
| 87220 | 3,262 | 3,078 | $4K | |
| 81374 | 107 | 92 | $4K | |
| 87807 | 866 | 849 | $4K | |
| 86701 | 2,823 | 2,474 | $4K | |
| 80184 | 689 | 635 | $4K | |
| 85305 | 950 | 884 | $4K | |
| 83986 | 1,411 | 1,297 | $4K | |
| 80335 | 482 | 403 | $4K | |
| 84300 | 2,977 | 2,635 | $4K | |
| 87116 | 874 | 679 | $4K | |
| 83527 | 557 | 541 | $4K | |
| 82180 | 954 | 877 | $3K | |
| 85230 | 454 | 447 | $3K | |
| 87254 | 262 | 255 | $3K | |
| 86790 | 594 | 428 | $3K | |
| 84252 | 452 | 397 | $3K | |
| 83930 | 1,106 | 999 | $3K | |
| 84140 | 406 | 362 | $3K | |
| 82642 | 277 | 250 | $3K | |
| 85270 | 477 | 460 | $3K | |
| 87272 | 898 | 826 | $2K | |
| 82523 | 668 | 553 | $2K | |
| 81339 | 78 | 61 | $2K | |
| 81207 | 55 | 50 | $2K | |
| 84133 | 1,630 | 1,460 | $2K | |
| 86905 | 1,963 | 1,868 | $2K | |
| 82552 | 377 | 340 | $2K | |
| 86663 | 331 | 300 | $2K | |
| 80201 | 399 | 375 | $2K | |
| 86632 | 618 | 589 | $2K | |
| 82308 | 173 | 154 | $2K | |
| 87015 | 1,234 | 990 | $2K | |
| 83945 | 459 | 398 | $2K | |
| 88307 | 14 | 14 | $2K | |
| 87230 | 260 | 236 | $2K | |
| 87184 | 717 | 643 | $2K | |
| 80203 | 229 | 222 | $2K | |
| G0328 | Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous | 8,325 | 6,462 | $2K |
| 82365 | 234 | 219 | $1K | |
| 81219 | 47 | 42 | $1K | |
| 84560 | 1,043 | 908 | $1K | |
| 88271 | 58 | 54 | $1K | |
| 85670 | 321 | 295 | $1K | |
| 81517 | 15 | 13 | $1K | |
| 84433 | 56 | 51 | $1K | |
| 81269 | 13 | 13 | $1K | |
| 85280 | 167 | 163 | $1K | |
| 85301 | 250 | 236 | $1K | |
| 86041 | 152 | 132 | $979.19 | |
| 84163 | 415 | 372 | $960.50 | |
| G0124 | Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, requiring interpretation by physician | 70 | 69 | $951.68 |
| 80503 | 86 | 78 | $951.41 | |
| 80158 | 107 | 79 | $946.35 | |
| 84442 | 158 | 142 | $932.93 | |
| 82681 | 105 | 95 | $901.39 | |
| 82671 | 42 | 42 | $894.03 | |
| 80371 | 88 | 80 | $865.27 | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 25 | 25 | $847.00 |
| 82656 | 251 | 213 | $792.08 | |
| G0475 | Hiv antigen/antibody, combination assay, screening | 148 | 136 | $786.41 |
| G0476 | Infectious agent detection by nucleic acid (dna or rna); human papillomavirus (hpv), high-risk types (e.g., 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68) for cervical cancer screening, must be performed in addition to pap test | 41 | 39 | $780.12 |
| 86316 | 135 | 117 | $779.90 | |
| 86215 | 104 | 99 | $763.09 | |
| G0472 | Hepatitis c antibody screening, for individual at high risk and other covered indication(s) | 1,178 | 953 | $755.63 |
| 88289 | 76 | 73 | $695.98 | |
| 87999 | 191 | 188 | $679.10 | |
| 84585 | 111 | 104 | $676.59 | |
| 84378 | 265 | 233 | $668.98 | |
| 84105 | 456 | 404 | $660.54 | |
| 87634 | 42 | 42 | $639.07 | |
| 87300 | 38 | 38 | $565.62 | |
| 80230 | 27 | 24 | $551.21 | |
| 81508 | 75 | 75 | $535.78 | |
| 81332 | 27 | 25 | $529.27 | |
| 80168 | 62 | 58 | $497.07 | |
| 82010 | 111 | 108 | $493.21 | |
| 86382 | 12 | 12 | $429.20 | |
| 84591 | 59 | 51 | $376.08 | |
| 87581 | 28 | 28 | $338.86 | |
| 85651 | 346 | 330 | $338.24 | |
| 82540 | 107 | 89 | $316.75 | |
| 89060 | 258 | 208 | $296.14 | |
| 86023 | 20 | 14 | $285.71 | |
| 82261 | 74 | 69 | $270.62 | |
| 87140 | 131 | 126 | $249.51 | |
| 84392 | 160 | 136 | $249.27 | |
| G0123 | Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, screening by cytotechnologist under physician supervision | 500 | 405 | $246.79 |
| 86606 | 33 | 26 | $233.63 | |
| 86362 | 31 | 26 | $231.78 | |
| 83018 | 13 | 13 | $224.25 | |
| 82941 | 63 | 52 | $188.81 | |
| 82634 | 17 | 14 | $180.41 | |
| 89051 | 241 | 198 | $173.87 | |
| 82436 | 88 | 84 | $172.05 | |
| 87207 | 103 | 87 | $147.53 | |
| 83919 | 34 | 30 | $132.95 | |
| 82978 | 27 | 25 | $118.58 | |
| 86710 | 16 | 15 | $99.25 | |
| 86615 | 13 | 12 | $92.22 | |
| 86043 | 15 | 13 | $89.03 | |
| 83497 | 12 | 12 | $82.88 | |
| 86042 | 15 | 13 | $81.58 | |
| 86609 | 19 | 12 | $80.89 | |
| 85307 | 12 | 12 | $63.77 | |
| 86022 | 20 | 16 | $54.34 | |
| G0306 | Complete cbc, automated (hgb, hct, rbc, wbc, without platelet count) and automated wbc differential count | 811 | 600 | $53.51 |
| 82595 | 35 | 24 | $52.32 | |
| 82131 | 14 | 13 | $49.70 | |
| G0307 | Complete (cbc), automated (hgb, hct, rbc, wbc; without platelet count) | 844 | 687 | $19.80 |
| 86999 | 143 | 82 | $6.21 | |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed | 67 | 53 | $2.07 |